Yes, we need more research, read this https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently
How the Marijuana Industry Can Solve the Schedule 1 Research Barrier on Cannabis
1. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 2/16
SCHEDULE 1 RESEARCH ON MARIJUANA
h bi d l h
ď Edit Article (https://cannabis.net/mycannabis/c-blog-entry/update/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently)
ď Article List (https://cannabis.net/mycannabis/c-blog)
2. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 3/16
How the Cannabis Industry Can Solve the
Schedule-1 Drug Research Barrier Problem
Weed Currently Faces
Research is forbidden on Schedule-1 drugs in the USA, so here is how weed can get around that
rule.
Posted by:
Reginald Reefer, today at 12:00am
The âPsychedelic Trainâ has left the station, or so NIDA Director Nora Volkow (https://cannabis.net/blog/opinion/a-look-
inside-the-mind-of-nora-volkov-the-new-head-of-the-national-institute-of-drug-abuse) said recently in an article
(https://www.marijuanamoment.net/top-federal-drug-official-says-train-has-left-the-station-on-psychedelics-as-reform-
3. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 4/16
movement-spreads/) covered by Marijuana Moment. Volkow, who has been the director of the National Institute on
Drug Abuse since 2003 has been a vocal advocate for more research on Schedule-I drugs. She also believes that there
will be an inevitability in the rise of the use of Psychedelics in the coming years.
In fact, the evidence suggests that psychedelics have risen in popularity since the start of the pandemic and they believe
it could be a means of âescapeâ from the anxieties produced by the global situation. Nonetheless, Volkow believes that
with the expanding research into the benefits of psychedelics more people will begin to utilize psychedelics by
themselves â which warrants expedited research in use, dose, effect, and so forth.
This is where Schedule-I become a major problem.
âResearchers must obtain a Schedule I registration which, unlike obtaining registrations for Schedule II substances (which
include fentanyl, methamphetamine, and cocaine), is administratively challenging and time consuming,â she said. âThis process
may deter some scientists from conducting research on Schedule I drugs.â (SOURCE: Marijuana Moment)
4. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 5/16
She also acknowledged the DEAâs willingness to increase the quota for research for certain psychedelic drugs.
âIt will also be important to streamline the process of obtaining Schedule I registrations to further the science on these
substances, including examining their therapeutic potential,â she said.
This made me think about the research barrier â the Schedule-I category. The entire system is set up to deter anyone
from even researching these drugs deemed âToo dangerous to study!â Fortunately, we are seeing a pushback from the
scientific community and the general public waking up to the fact that prohibition isnât working.
Due to this shift in paradigm, the DEA was forced to shift their stance on certain drugs. First with cannabis and now with
psychedelics. The public had to twist the arm of the government in order to have them say, âSure weâre thinking about
making it easier to researchâŚjust give us time!â
5. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 6/16
And so, one year leads to two and eventually a decade has blown by and virtually no headway was made in researching
the therapeutic potentials of these drugs, their potential risk factors and so forth.
This makes you wonder â why do we have the Controlled Substance Act in the first place?
The origins of the Controlled Substance Act
The Controlled Substance Act was the second piece of policy from a much larger act entitled, âComprehensive Drug
Abuse Prevention and Control Act of 1970â. Nixon, who announced this in his short run as president until he was
impeached for obstruction of justice, abuse of power and contempt for Congress.
âWhile Nixon himself was not impeached, the impeachment process against him is so far the only one to cause a president's
departure from office.â - Source (https://colors-newyork.com/why-did-president-nixon-get-impeached/)
Nonetheless, Nixon essentially handed the entire US Drug Market over to the pharmaceutical companies
(https://cannabis.net/blog/history/why-is-cannabis-still-illegal) who would be in charge of âcertain types of drugsâ, while
the rest of the drugs that was deemed âunmarketable to the massesâ were left under the jurisdiction of the DEA, who
would then begin to utilize federal funds to wage a war that would last for several decades.
Hereâs an excerpt from Wikipedia on the Act;
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub.L. 91â513, 84 Stat. 1236, enacted October 27, 1970, is
a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical
security and strict record keeping for certain types of drugs.[1] Controlled substances are divided into five schedules (or
classes) on the basis of their potential for abuse, accepted medical use, and accepted safety under medical supervision.
Substances in Schedule I have a high potential for abuse, no accredited medical use, and a lack of accepted safety.
From Schedules II to V, substances decrease in potential for abuse. The schedule a substance is placed in determines how it
must be controlled. Prescriptions for drugs in all schedules must bear the physician's federal Drug Enforcement
Administration (DEA) license number, but some drugs in Schedule V do not require a prescription. State schedules may vary
from federal schedules.
6. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 7/16
The Controlled Substances Act (CSA), Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, is the legal
foundation of the government's fight against the abuse of drugs and other substances. This law is a consolidation of
numerous laws regulating the manufacture and distribution of narcotics, stimulants, depressants, hallucinogens,
anabolic steroids, and chemicals used in the illicit production of controlled substances. The act also provides a
mechanism for substances to be controlled, added to a schedule, decontrolled, removed from control, rescheduled, or
transferred from one schedule to another.[2] â SOURCE
(https://en.wikipedia.org/wiki/Comprehensive_Drug_Abuse_Prevention_and_Control_Act_of_1970)
As you can see, the underlying mechanism here is that;
1. The Pharmaceutical Industry keeps record and stores all the drugs
2. The DEA and FDA regulate the Scheduling
3. Congress has powers to add and remove substances
While this seems like a good idea on paper, when you realize that roughly 75% of the FDAâs budget
(https://www.forbes.com/sites/johnlamattina/2018/06/28/the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-
review-budget-is-this-a-problem/) comes from the Biopharmaceutical industry. Science
(https://www.science.org/content/article/hidden-conflicts-pharma-payments-fda-advisers-after-drug-approvals-spark-
ethical).org also found that the pharmaceutical industry pays researches plenty of âside benefitsâ which may possibly
influence their assessments on certain drugs.
One way to look at this set up after learning about the finances is that the US government gave the pharmaceutical
industry monopoly over drugs and through funding the FDA has a stake in the regulatory process. Furthermore, the DEA
can actively use federal resources to literally wage war against any âblack market competitionâ the pharmaceutical
industry could face.
Of course, the system isnât as singular-focused as described above, but if one were feeling a bit conspiratorial, this
wouldnât be a hard pill to swallow. Rather, the Act that was signed in by Nixon represents a conglomerate of special
interests creating âspecial rulesâ for the status quo in the name of health and safety.
7. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 8/16
However, as we now learn about the therapeutic benefits of cannabis and psychedelics, we can clearly see that the
prohibition in research had nothing to do with public health and safety, and everything to do with control and finance.
Therefore, instead of trying to patchwork the CSA to allow psychedelics and other drugs to be research, perhaps itâs
time to completely nullify the CSA and rework our global approach to drugs (https://cannabis.net/blog/opinion/is-it-
time-to-nullify-the-controlled-substance-act-the-nida-may-agree-with-you-now). A policy in where we decide to stop
arresting users, focus on education & prevention while increasing the safety profile of the drugs themselves.
Research barrier SOLVED!
MORE ON THE CSA AND FEDERAL SCHEDULING, READ THESE...
(https://cannabis.net/blog/news/dea-reschedules-some-forms-of-cbd-to-
schedule-5-what-the-does-that-mean)
WHY DID THE DEA JUST MOVE SOME FORMS OF CBD TO SCHEDULE 5 DRUGS? (https://cannabis.net/blog/news/dea-
reschedules-some-forms-of-cbd-to-schedule-5-what-the-does-that-mean)
OR..
8. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 9/16
(https://cannabis.net/blog/opinion/california-urges-the-us-congress-to-
reschedule-cannabis-immediately)
CALIFORNIA PUSHES FOR MARIJUANA TO BE RESCHEDULED NOW! (https://cannabis.net/blog/opinion/california-
urges-the-us-congress-to-reschedule-cannabis-immediately)
What did you think?
  Keep reading... click here Â
(https://cannabis.net/blog)
0 0 0 0 0 0
9. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 10/16
Leave a Comment:
Submit
What are your thoughts?
CATEGORIES
10. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 11/16
B2B (HTTPS://CANNABIS.NET/BLOG/B2B) LOCATIONS (HTTPS://CANNABIS.NET/BLOG/LOCATIONS)
EVENTS (HTTPS://CANNABIS.NET/BLOG/EVENTS) HOW TO (HTTPS://CANNABIS.NET/BLOG/HOW-TO)
NEWS (HTTPS://CANNABIS.NET/BLOG/NEWS) STRAINS (HTTPS://CANNABIS.NET/BLOG/STRAINS)
SPORTS (HTTPS://CANNABIS.NET/BLOG/SPORTS) VOTE (HTTPS://CANNABIS.NET/BLOG/VOTE)
SEXY (HTTPS://CANNABIS.NET/BLOG/SEXY) RECIPES (HTTPS://CANNABIS.NET/BLOG/RECIPES)
DABS (HTTPS://CANNABIS.NET/BLOG/DABS) VAPING (HTTPS://CANNABIS.NET/BLOG/VAPING)
INTERVIEW (HTTPS://CANNABIS.NET/BLOG/INTERVIEW) MEDICAL (HTTPS://CANNABIS.NET/BLOG/MEDICAL)
PERSONAL STORY (HTTPS://CANNABIS.NET/BLOG/PERSONAL-STORY)
TECHNOLOGY (HTTPS://CANNABIS.NET/BLOG/TECHNOLOGY) OPINION (HTTPS://CANNABIS.NET/BLOG/OPINION)
VIDEOS (HTTPS://CANNABIS.NET/BLOG/VIDEOS) HISTORY (HTTPS://CANNABIS.NET/BLOG/HISTORY)
SMOKE (HTTPS://CANNABIS.NET/BLOG/SMOKE) FUNNY (HTTPS://CANNABIS.NET/BLOG/FUNNY)
FEATURED
11. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 12/16
(https://cannabis.net/blog/opinion/dropping-acid-with-my-mom-bucket-list-3-now-gone)
OPINION
Dropping Acid with My Mom - Bucket List #3 Now Gone
Next, it was important to make sure that my mom was prepared for the experience. The nearest-hallucinogenic experience she had in the past was an âoverdose
of potent browniesâ. While hallucinations are common in this experience, itâs nothing compared to the LSD hallucination.
12. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 13/16
NEWS
Japanese Youth Resistant To Laws Prohibiting Cannabis
While the number of cases involving cannabis increases, the number of cases that have been investigated for association with stimulant drugs saw a slight drop
to 10,113 from the year before, while cocaine-associated cases increased dramatically to 177 from 2013.
13. 1/23/22, 8:51 AM How the Cannabis Industry Can Solve the Schedule-1 Drug Research Barrier Problem Weed Currently Faces
https://cannabis.net/blog/opinion/how-the-cannabis-industry-can-solve-the-schedule1-drug-research-barrier-problem-weed-currently 14/16
(https://cannabis.net/blog/news/japanese-youth-resistant-to-laws-prohibiting-cannabis)